Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NateP
    Junior Member
    • Sep 2011
    • 9

    #1

    FDR in RNA-Seq with Multiple Pairwise Tests

    Okay, I guess this is more of a statistics question than a program question, but I just want to clarify something dealing with the correct usage of FDR with multiple tests.

    General Experiment Set:
    3 Biological Replicates of samples collected from 4 time points (t1, t2, t3, t4).

    The question is how is t1 different from each of t2, t3, and t4 individually.

    So using DESeq, I basically did 3 pairwise tests: t1 vs t2, t1 vs t3, t1 vs t4. And of course, DESeq gives FDR values for each of those test pairs.

    However, since I am technically doing 3 tests on the same data set, is the appopriate statistical approach to carry out an FDR correction on all of the tests as a whole?

    In other works, take the raw p-values from all 3 tests, and combine them in a single list and then FDR correct (like using p.adjust, method="BH"), and afterwords break the whole set back into the original 3 tests again.

    Or is just using the FDR values generated from the 3 pairwise tests separately statistically valid?
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    The three time point comparisons are done independently, not simultaneously. You are comparing three hypotheses - that each time point, independently, is different from the controls. So the only multiplicity you need correct for is the simultaneous pairwise tests you do each time you test one of those three hyptotheses.

    It would be analogous to performing orthogonal linear contrasts in an ANOVA, where you would correct each linear contrast for multiple tests independently of each other.
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...